Who
Jonathan Philip Siegrist
EVP of R&D & CTO
Company insider
Files Form 4 as: EVP of R&D & CTO, QuidelOrtho.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Jan 2025
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code M | —18,657 at $0.00 | filing |
| 15 Oct 2026filed 19 Oct 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code F | $93K6,695 at $13.91 | filing |
| 15 Oct 2026filed 19 Oct 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —18,657 at $0.00 | filing |
| 30 Jan 2026filed 3 Feb 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —36,152 at $0.00 | filing |
| 30 Jan 2026filed 3 Feb 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —36,150 at $0.00 | filing |
| 30 Jan 2026filed 3 Feb 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —36,152 at $0.00 | filing |
| 30 Jan 2026filed 3 Feb 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —36,150 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —2,448 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code F | $28K1,009 at $27.41 | filing |
| 29 Jan 2026filed 2 Feb 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,448 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,448 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —2,448 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code F | $28K1,009 at $27.41 | filing |
| 15 Oct 2025filed 17 Oct 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —18,656 at $0.00 | filing |
| 15 Oct 2025filed 17 Oct 2025 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —18,656 at $0.00 | filing |
| 15 Oct 2025filed 17 Oct 2025 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code F | $182K6,676 at $27.31 | filing |
| 29 Jan 2025filed 31 Jan 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —7,346 at $0.00 | filing |
| 29 Jan 2025filed 31 Jan 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —7,347 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.